NCT06475001: Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain
- State
- Completed
- Phase
- Phase 2
- People
- 652 taking part
- Started
- 28 Jun 2024
- Primary completion
- 31 Jul 2025
- Arms
- VER-01
- Results
- None posted
- 26 Jun 2024: Trial registered
- 28 Jun 2024: Trial started
- 31 Jul 2025: Trial completed